MAPT and neurodegenerative disease: Although investigators have developed numerous genetic models of brain degeneration, including models that feature tau or amyloid deposition, each model has limited applicability to brain degeneration in general, and it can be difficult to distinguish the idiosyncratic from the generalizable features of each model.